Who
Mary Elizabeth Henderson
SVP, Technical Operations
Company insider
Files Form 4 as: SVP, Technical Operations, Jazz Pharmaceuticals.
In numbers
- Trades disclosed
- 24
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $2.6M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 11 Aug 2023
- Last trade
- 8 Sep 2026
- Last filed
- 10 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Sep 2026filed 10 Sep 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $343K1,412 at $243.03 | filing |
| 8 Sep 2026filed 10 Sep 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $3,61815 at $241.20 | filing |
| 8 Sep 2026filed 10 Sep 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $343K1,412 at $243.03 | filing |
| 8 Sep 2026filed 10 Sep 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $3,61815 at $241.20 | filing |
| 31 Aug 2026filed 2 Sep 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $501K2,076 at $241.39 | filing |
| 31 Aug 2026filed 2 Sep 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $3,91416 at $244.64 | filing |
| 31 Aug 2026filed 2 Sep 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $501K2,076 at $241.39 | filing |
| 31 Aug 2026filed 2 Sep 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $3,91416 at $244.64 | filing |
| 5 Mar 2026filed 9 Mar 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $260K1,394 at $186.75 | filing |
| 5 Mar 2026filed 9 Mar 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $260K1,394 at $186.75 | filing |
| 26 Feb 2026filed 2 Mar 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —4,447 at $0.00 | filing |
| 26 Feb 2026filed 2 Mar 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $1.0M5,343 at $194.49 | filing |
| 26 Feb 2026filed 2 Mar 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —4,447 at $0.00 | filing |
| 26 Feb 2026filed 2 Mar 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $1.0M5,343 at $194.49 | filing |
| 16 Jan 2026filed 21 Jan 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —10,116 at $0.00 | filing |
| 16 Jan 2026filed 21 Jan 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —10,116 at $0.00 | filing |
| 9 Dec 2025filed 11 Dec 2025 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $379K2,238 at $169.51 | filing |
| 19 Nov 2025filed 21 Nov 2025 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code D | $240K1,331 at $180.40 | filing |
| 7 Mar 2025filed 11 Mar 2025 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code D | $96K698 at $138.23 | filing |
| 27 Feb 2025filed 3 Mar 2025 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —5,392 at $0.00 | filing |
News
Jazz Pharmaceuticals gets Cramer's vote of confidenceJAZZ · aol.com · 14 Oct 2026Critical Analysis: vTv Therapeutics (NASDAQ:VTVT) and Jazz Pharmaceuticals (NASDAQ:JAZZ)JAZZ · tickerreport.com · 12 Oct 2026Cramer's lightning round: 'I'm going to say yes to Jazz Pharmaceuticals'JAZZ · cnbc.com · 10 Oct 2026
0 headlines in the last 90 days name Mary Elizabeth Henderson; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.